Showing 51-60 of 9511 results for "".
- Dietary Allergens, Air Pollution, Humidity Linked to Pediatric Atopic Dermatitishttps://practicaldermatology.com/news/dietary-allergens-air-pollution-humidity-linked-to-pediatric-atopic-dermatitis/2488526/Dietary allergen sensitization and environmental exposures were associated with pediatric atopic dermatitis (AD) in a 2-stage study published in Frontiers in Pediatrics.
- LEO Pharma Closes Dersimelagon Acquisition as FDA Accepts NDAhttps://practicaldermatology.com/news/leo-pharma-closes-dersimelagon-acquisition-as-fda-accepts-nda/2488489/LEO Pharma announced that the US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for dersimelagon for filing and granted Priority Review for the investigational treatment of erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP). The FDA has se
- Anzupgo Receives Positive CHMP Opinion for Adolescent CHEhttps://practicaldermatology.com/news/anzupgo-receives-positive-chmp-opinion-for-adolescent-che/2488490/The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the indication for Anzupgo (delgocitinib) cream to adolescents aged 12 to 17 years with moderate to severe chronic hand eczema (CHE) for whom topical corticosteroids are inadequate or i
- Dupilumab Shows Sustained Effectiveness Through 3 Years in Pediatric Atopic Dermatitis: Analysishttps://practicaldermatology.com/news/dupilumab-shows-sustained-effectiveness-through-3-years-in-pediatric-atopic-dermatitis-analysis/2488475/Dupilumab demonstrated sustained effectiveness and a 3-year drug survival rate of 80.1% among pediatric patients with moderate to severe atopic dermatitis (AD) in a prospective real-world cohort published in JAMA Derma
- Report: Estimated 4.7 Million Americans Diagnosed With NMSC Annuallyhttps://practicaldermatology.com/news/report-estimated-47-million-americans-diagnosed-with-nmsc-annually/2488474/A new analysis from SkinCure Oncology estimates that 4.7 million Americans are diagnosed with nonmelanoma skin cancer (NMSC) each, approximately 42% higher than a commonly cited estimate based on 2012 data.
- Sun Pharma Partners with Christian Siriano for Alopecia Areata Awareness Campaignhttps://practicaldermatology.com/news/sun-pharma-partners-with-christian-siriano-for-alopecia-areata-awareness-campaign/2488473/Sun Pharma announced a partnership with fashion designer Christian Siriano on "Regrowth Restyled," a new awareness campaign focused on confidence, self-expression and hair growth support for adults living with severe alopecia areata. Launched during Alopecia Areata Awareness Month, the cam
- Rubedo Plans Clinical Trial of RLS-1496 for Androgenetic Alopeciahttps://practicaldermatology.com/news/rubedo-plans-clinical-trial-of-rls-1496-for-androgenetic-alopecia/2488446/Rubedo Life Sciences announced plans to evaluate its investigational GPX4 modulator RLS-1496 in patients with androgenetic alopecia (AGA), following ex vivo findings showing increased growth of human hair follicles exposed to the agent, according to an a
- Meta-Analysis: IBD Events Are Rare With IL-17 Inhibitors in HShttps://practicaldermatology.com/news/meta-analysis-finds-rare-ibd-events-with-il-17-inhibitors-in-hs/2488443/Interleukin (IL)-17 inhibitors were not associated with a statistically significant increase in inflammatory bowel disease (IBD) risk among patients with hidradenitis suppurativa (HS) in a systematic review and meta-analysis published online in JAMA Dermatology. IBD Events Remain
- FDA Approves Ameluz PDT for Superficial Basal Cell Carcinomahttps://practicaldermatology.com/news/fda-approves-ameluz-pdt-for-superficial-basal-cell-carcinoma/2488430/The US Food and Drug Administration (FDA) has approved Biofrontera Inc.’s supplemental New Drug Application for Ameluz (aminolevulinic acid hydrochloride) topical gel, 10%, in combination with photodynamic therapy (PDT) using the BF-RhodoLED lamp series for the treatment of superficial basal cell
- Smoke Exposure Associated With Higher Odds of Pediatric Hidradenitis Suppurativahttps://practicaldermatology.com/news/smoke-exposure-associated-with-higher-odds-of-pediatric-hidradenitis-suppurativa/2488418/Active and passive smoke exposure were associated with higher odds of hidradenitis suppurativa (HS) among pediatric and adolescent patients in a retrospective case-control study published in Pediatric Dermatology.